Cash Flow Tianjin TEDA Biomedical Engineering Co. Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
-122.00
-41.00
-13.00
-34.00
-55.00
-54.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-76.00
-19.00
-4.00
-2.00
-6.00
48.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-59.00
-28.00
-14.00
-14.00
-7.00
41.00
Cash Flow from Investing Activities
33.00
-40.00
0.00
-15.00
-10.00
-30.00
Cash Flow from Financing Activities
29.00
89.00
14.00
7.00
33.00
-22.00
Net Cash Inflow / Outflow
4.00
21.00
0.00
-22.00
15.00
-12.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Tianjin TEDA Biomedical Engineering Co. Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
-122.477601530935
-832.995287969797
710.00
85.30%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-76.2266024906466
355.463379988908
-431.00
-121.44%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-59.1142281584087
179.597070192101
-238.00
-132.91%
Cash Flow from Investing Activities
33.9349141317438
-52.7392869949982
85.00
164.34%
Cash Flow from Financing Activities
29.3131180112592
-636.906955402448
665.00
104.60%
Net Cash Inflow / Outflow
4.13380398459422
-511.133695576069
515.00
100.81%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
-1.08452337072525
1.00
100.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
YoY Growth in year ended Dec 2025 is -107.92% vs -99.39% in Dec 2024
Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
-59.11
-28.43
-107.92%
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
